APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sepsis Treatment

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Selected research

Market Analysis & Forecast

Global Sepsis Treatment Market Analysis and Forecast 2026-2032

27 December 2025203 pages

Choose your research edition.

Industry ResearchSepsis Treatment Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Sepsis Treatment Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Sepsis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sepsis Treatment Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Sepsis Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.

Report Includes

Read the full market overview

This report presents an overview of global market for Sepsis Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sepsis Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Sepsis Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sepsis Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sepsis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Sepsis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Sepsis Treatment Segment by Company

Pfizer

NCPC

Bayer

Shanghai Pharmaceuticals

Johnson & Johnson

Novartis

GlaxoSmithKline

TEVA

Mylan

Allergan

Merck & Co

Asahi Kasei Corporation

AtoxBio

INOTREM

Adrenomed

Endacea

Sepsis Treatment Segment by Type

Cephalosporin

Pencillin

Macrolides

Others

Sepsis Treatment Segment by Application

Sepsis

Severe Sepsis

Septic Shock

Sepsis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sepsis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Sepsis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Sepsis Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sepsis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cephalosporin Major Player Table 3. Pencillin Major Player Table 4. Macrolides Major Player Table 5. Others Major Player Table 6. Global Sepsis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Sepsis Major Player Table 8. Severe Sepsis Major Player Table 9. Septic Shock Major Player Table 10. Sepsis Treatment Industry Trends Table 11. Sepsis Treatment Industry Drivers Table 12. Sepsis Treatment Industry Opportunities and Challenges Table 13. Sepsis Treatment Industry Restraints Table 14. Global Sepsis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Sepsis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Sepsis Treatment Market Share by Region (2021-2026) Table 17. Global Sepsis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Sepsis Treatment Market Share by Region (2027-2032) Table 19. Global Sepsis Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Sepsis Treatment Revenue Market Share by Players (2021-2026) Table 21. Global Sepsis Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Sepsis Treatment Key Players Headquarters & Area Served Table 23. Global Sepsis Treatment Players, Product Type & Application Table 24. Global Sepsis Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Sepsis Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Sepsis Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Sepsis Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Sepsis Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Sepsis Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Sepsis Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Sepsis Treatment Revenue Market Share by Application (2027-2032) Table 37. Pfizer Company Information Table 38. Pfizer Business Overview Table 39. Pfizer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Pfizer Sepsis Treatment Product Portfolio Table 41. Pfizer Recent Development Table 42. NCPC Company Information Table 43. NCPC Business Overview Table 44. NCPC Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. NCPC Sepsis Treatment Product Portfolio Table 46. NCPC Recent Development Table 47. Bayer Company Information Table 48. Bayer Business Overview Table 49. Bayer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bayer Sepsis Treatment Product Portfolio Table 51. Bayer Recent Development Table 52. Shanghai Pharmaceuticals Company Information Table 53. Shanghai Pharmaceuticals Business Overview Table 54. Shanghai Pharmaceuticals Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Shanghai Pharmaceuticals Sepsis Treatment Product Portfolio Table 56. Shanghai Pharmaceuticals Recent Development Table 57. Johnson & Johnson Company Information Table 58. Johnson & Johnson Business Overview Table 59. Johnson & Johnson Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Johnson & Johnson Sepsis Treatment Product Portfolio Table 61. Johnson & Johnson Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Novartis Sepsis Treatment Product Portfolio Table 66. Novartis Recent Development Table 67. GlaxoSmithKline Company Information Table 68. GlaxoSmithKline Business Overview Table 69. GlaxoSmithKline Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GlaxoSmithKline Sepsis Treatment Product Portfolio Table 71. GlaxoSmithKline Recent Development Table 72. TEVA Company Information Table 73. TEVA Business Overview Table 74. TEVA Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. TEVA Sepsis Treatment Product Portfolio Table 76. TEVA Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Mylan Sepsis Treatment Product Portfolio Table 81. Mylan Recent Development Table 82. Allergan Company Information Table 83. Allergan Business Overview Table 84. Allergan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Allergan Sepsis Treatment Product Portfolio Table 86. Allergan Recent Development Table 87. Merck & Co Company Information Table 88. Merck & Co Business Overview Table 89. Merck & Co Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 90. Merck & Co Sepsis Treatment Product Portfolio Table 91. Merck & Co Recent Development Table 92. Asahi Kasei Corporation Company Information Table 93. Asahi Kasei Corporation Business Overview Table 94. Asahi Kasei Corporation Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 95. Asahi Kasei Corporation Sepsis Treatment Product Portfolio Table 96. Asahi Kasei Corporation Recent Development Table 97. AtoxBio Company Information Table 98. AtoxBio Business Overview Table 99. AtoxBio Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 100. AtoxBio Sepsis Treatment Product Portfolio Table 101. AtoxBio Recent Development Table 102. INOTREM Company Information Table 103. INOTREM Business Overview Table 104. INOTREM Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 105. INOTREM Sepsis Treatment Product Portfolio Table 106. INOTREM Recent Development Table 107. Adrenomed Company Information Table 108. Adrenomed Business Overview Table 109. Adrenomed Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 110. Adrenomed Sepsis Treatment Product Portfolio Table 111. Adrenomed Recent Development Table 112. Endacea Company Information Table 113. Endacea Business Overview Table 114. Endacea Sepsis Treatment Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 115. Endacea Sepsis Treatment Product Portfolio Table 116. Endacea Recent Development Table 117. North America Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Sepsis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Sepsis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Sepsis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Sepsis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 131. China Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 132. China Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 133. China Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 134. China Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Sepsis Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Sepsis Treatment Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Sepsis Treatment Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Sepsis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Sepsis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Sepsis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Sepsis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Sepsis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Sepsis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Sepsis Treatment Image Figure 2. Global Sepsis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sepsis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cephalosporin Image Figure 5. Pencillin Image Figure 6. Macrolides Image Figure 7. Others Image Figure 8. Global Sepsis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Sepsis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. Sepsis Image Figure 11. Severe Sepsis Image Figure 12. Septic Shock Image Figure 13. Global Sepsis Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global Sepsis Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Sepsis Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Sepsis Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Sepsis Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Sepsis Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Sepsis Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Sepsis Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Sepsis Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Sepsis Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Sepsis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Sepsis Treatment Revenue Share by Type (2021-2032) Figure 26. North America Sepsis Treatment Revenue Share by Application (2021-2032) Figure 27. North America Sepsis Treatment Revenue Share by Country (2021-2032) Figure 28. United States Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Sepsis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Sepsis Treatment Revenue Share by Type (2021-2032) Figure 33. Europe Sepsis Treatment Revenue Share by Application (2021-2032) Figure 34. Europe Sepsis Treatment Revenue Share by Country (2021-2032) Figure 35. Germany Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Sepsis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Sepsis Treatment Revenue Share by Type (2021-2032) Figure 45. China Sepsis Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Sepsis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Sepsis Treatment Revenue Share by Type (2021-2032) Figure 48. Asia Sepsis Treatment Revenue Share by Application (2021-2032) Figure 49. Asia Sepsis Treatment Revenue Share by Region (2021-2032) Figure 50. Japan Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Sepsis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Sepsis Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA Sepsis Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA Sepsis Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Sepsis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporin
  • Pencillin
  • Macrolides
  • Others
Applications
  • Sepsis
  • Severe Sepsis
  • Septic Shock
Companies covered
  • Pfizer
  • NCPC
  • Bayer
  • Shanghai Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • GlaxoSmithKline
  • TEVA
  • Mylan
  • Allergan
  • Merck & Co
  • Asahi Kasei Corporation
  • AtoxBio
  • INOTREM
  • Adrenomed
  • Endacea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sepsis Treatment Market by Type
  3. 1.2.1 Global Sepsis Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cephalosporin
  5. 1.2.3 Pencillin
  6. 1.2.4 Macrolides
  7. 1.2.5 Others
  8. 1.3 Sepsis Treatment Market by Application
  9. 1.3.1 Global Sepsis Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Sepsis
  11. 1.3.3 Severe Sepsis
  12. 1.3.4 Septic Shock
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Sepsis Treatment Market Dynamics
  1. 2.1 Sepsis Treatment Industry Trends
  2. 2.2 Sepsis Treatment Industry Drivers
  3. 2.3 Sepsis Treatment Industry Opportunities and Challenges
  4. 2.4 Sepsis Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Sepsis Treatment Market Perspective (2021-2032)
  2. 3.2 Global Sepsis Treatment Growth Trends by Region
  3. 3.2.1 Global Sepsis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sepsis Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Sepsis Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Sepsis Treatment Revenue by Players
  2. 4.1.1 Global Sepsis Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Sepsis Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Sepsis Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sepsis Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Sepsis Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Sepsis Treatment Players, Product Type & Application
  8. 4.5 Global Sepsis Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Sepsis Treatment Market CR5 and HHI
  11. 4.6.3 2025 Sepsis Treatment Tier 1, Tier 2, and Tier 3
5 Sepsis Treatment Market Size by Type
  1. 5.1 Global Sepsis Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Sepsis Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Sepsis Treatment Revenue Market Share by Type (2021-2032)
6 Sepsis Treatment Market Size by Application
  1. 6.1 Global Sepsis Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Sepsis Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Sepsis Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Sepsis Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Sepsis Treatment Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 NCPC
  8. 7.2.1 NCPC Company Information
  9. 7.2.2 NCPC Business Overview
  10. 7.2.3 NCPC Sepsis Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NCPC Sepsis Treatment Product Portfolio
  12. 7.2.5 NCPC Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Sepsis Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Sepsis Treatment Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Shanghai Pharmaceuticals
  20. 7.4.1 Shanghai Pharmaceuticals Company Information
  21. 7.4.2 Shanghai Pharmaceuticals Business Overview
  22. 7.4.3 Shanghai Pharmaceuticals Sepsis Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Pharmaceuticals Sepsis Treatment Product Portfolio
  24. 7.4.5 Shanghai Pharmaceuticals Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson Sepsis Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson Sepsis Treatment Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Sepsis Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Sepsis Treatment Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Sepsis Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Sepsis Treatment Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 TEVA
  44. 7.8.1 TEVA Company Information
  45. 7.8.2 TEVA Business Overview
  46. 7.8.3 TEVA Sepsis Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TEVA Sepsis Treatment Product Portfolio
  48. 7.8.5 TEVA Recent Developments
  49. 7.9 Mylan
  50. 7.9.1 Mylan Company Information
  51. 7.9.2 Mylan Business Overview
  52. 7.9.3 Mylan Sepsis Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Sepsis Treatment Product Portfolio
  54. 7.9.5 Mylan Recent Developments
  55. 7.10 Allergan
  56. 7.10.1 Allergan Company Information
  57. 7.10.2 Allergan Business Overview
  58. 7.10.3 Allergan Sepsis Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Allergan Sepsis Treatment Product Portfolio
  60. 7.10.5 Allergan Recent Developments
  61. 7.11 Merck & Co
  62. 7.11.1 Merck & Co Company Information
  63. 7.11.2 Merck & Co Business Overview
  64. 7.11.3 Merck & Co Sepsis Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Merck & Co Sepsis Treatment Product Portfolio
  66. 7.11.5 Merck & Co Recent Developments
  67. 7.12 Asahi Kasei Corporation
  68. 7.12.1 Asahi Kasei Corporation Company Information
  69. 7.12.2 Asahi Kasei Corporation Business Overview
  70. 7.12.3 Asahi Kasei Corporation Sepsis Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Asahi Kasei Corporation Sepsis Treatment Product Portfolio
  72. 7.12.5 Asahi Kasei Corporation Recent Developments
  73. 7.13 AtoxBio
  74. 7.13.1 AtoxBio Company Information
  75. 7.13.2 AtoxBio Business Overview
  76. 7.13.3 AtoxBio Sepsis Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AtoxBio Sepsis Treatment Product Portfolio
  78. 7.13.5 AtoxBio Recent Developments
  79. 7.14 INOTREM
  80. 7.14.1 INOTREM Company Information
  81. 7.14.2 INOTREM Business Overview
  82. 7.14.3 INOTREM Sepsis Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 INOTREM Sepsis Treatment Product Portfolio
  84. 7.14.5 INOTREM Recent Developments
  85. 7.15 Adrenomed
  86. 7.15.1 Adrenomed Company Information
  87. 7.15.2 Adrenomed Business Overview
  88. 7.15.3 Adrenomed Sepsis Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Adrenomed Sepsis Treatment Product Portfolio
  90. 7.15.5 Adrenomed Recent Developments
  91. 7.16 Endacea
  92. 7.16.1 Endacea Company Information
  93. 7.16.2 Endacea Business Overview
  94. 7.16.3 Endacea Sepsis Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Endacea Sepsis Treatment Product Portfolio
  96. 7.16.5 Endacea Recent Developments
8 North America
  1. 8.1 North America Sepsis Treatment Revenue (2021-2032)
  2. 8.2 North America Sepsis Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Sepsis Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Sepsis Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Sepsis Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Sepsis Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Sepsis Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Sepsis Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Sepsis Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Sepsis Treatment Revenue by Country
  11. 8.6.1 North America Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Sepsis Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Sepsis Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Sepsis Treatment Revenue (2021-2032)
  2. 9.2 Europe Sepsis Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Sepsis Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Sepsis Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Sepsis Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Sepsis Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Sepsis Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Sepsis Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Sepsis Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Sepsis Treatment Revenue by Country
  11. 9.6.1 Europe Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Sepsis Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Sepsis Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Sepsis Treatment Revenue (2021-2032)
  2. 10.2 China Sepsis Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Sepsis Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Sepsis Treatment Revenue by Type (2027-2032)
  5. 10.3 China Sepsis Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Sepsis Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Sepsis Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Sepsis Treatment Revenue by Application (2027-2032)
  9. 10.5 China Sepsis Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sepsis Treatment Revenue (2021-2032)
  2. 11.2 Asia Sepsis Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Sepsis Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Sepsis Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Sepsis Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Sepsis Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Sepsis Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Sepsis Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Sepsis Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Sepsis Treatment Revenue by Country
  11. 11.6.1 Asia Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Sepsis Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Sepsis Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sepsis Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Sepsis Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Sepsis Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Sepsis Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Sepsis Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Sepsis Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Sepsis Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Sepsis Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Sepsis Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Sepsis Treatment Revenue by Country
  11. 12.6.1 SAMEA Sepsis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Sepsis Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Sepsis Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst